Summit Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $507k | 194k | 2.61 |
| 2023-09-30 | $359k | 192k | 1.87 |
| 2023-06-30 | $881k | 351k | 2.51 |
| 2023-03-31 | $772k | 441k | 1.75 |
| 2022-12-31 | $236k | 56k | 4.25 |
| 2022-06-30 | $34k | 34k | 0.99 |
| 2022-03-31 | $90k | 37k | 2.45 |
| 2021-12-31 | $126k | 47k | 2.68 |
| 2021-09-30 | $208k | 42k | 5.01 |
| 2021-03-31 | $508k | 87k | 5.87 |
| 2020-12-31 | $164k | 35k | 4.71 |